Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Exercise or conversion SVP & GENERAL COUNSEL acquired 4,101 shares (option exercise)
  3. 4 Other disposition SVP & GENERAL COUNSEL disposed of 39,709 shares (other)
  4. 4 Open-market sale 10% owner sold 140,000 shares at $7.56 ($1,058,400)
  5. 4 Open-market sale Director sold 140,000 shares at $7.56 ($1,058,400)
  6. 4 Open-market sale Director sold 210,809 shares at an average $7.38 ($1,554,954)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Exercise or conversion President and CEO acquired 7,394 shares (option exercise)
  20. 4 Open-market sale Director sold 205,800 shares at an average $4.22 ($867,734)

Page 15 of 23 · 459 filings